SHUFRO ROSE & CO LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 287 filers reported holding NOVOCURE LTD in Q3 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHUFRO ROSE & CO LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2021$288,000
-5.3%
1,300
-43.5%
0.02%
-8.3%
Q1 2021$304,000
-46.8%
2,300
-30.3%
0.02%
-50.0%
Q4 2020$571,000
+55.6%
3,3000.0%0.05%
+33.3%
Q3 2020$367,000
+81.7%
3,300
+10.0%
0.04%
+50.0%
Q1 2020$202,000
-60.6%
3,000
-50.8%
0.02%
-47.8%
Q4 2019$513,000
-4.8%
6,100
-15.3%
0.05%
-14.8%
Q3 2019$539,0007,2000.05%
Other shareholders
NOVOCURE LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$24,386,00014.72%
HARTLINE INVESTMENT CORP/ 335,191$58,001,0008.32%
Deep Track Capital, LP 1,341,300$93,220,0006.13%
MORGAN JESS S & CO INC 48,345$3,360,0003.48%
Taylor Frigon Capital Management LLC 68,908$4,789,0002.49%
HighVista Strategies LLC 28,007$1,946,0001.18%
Private Harbour Investment Management & Counsel, LLC 13,106$911,0001.01%
Lloyd Park, LLC 9,325$648,0000.68%
Baillie Gifford 9,116,230$633,578,0000.65%
HAP Trading, LLC 110,900$10,575,0000.53%
View complete list of NOVOCURE LTD shareholders